期刊文献+

结直肠癌周期蛋白E和生存素的表达及临床意义 被引量:3

Expression and Clinical Significance of Cyclin E and Survivin in Colorectal Cancer
下载PDF
导出
摘要 目的探究结直肠癌中周期蛋白E和生存素的表达及临床意义。方法选取2018年1月至2021年9月于安徽医科大学附属第三医院进行手术切除治疗的60例结直肠癌患者的结直肠癌组织,对选取的标本进行分级、分期等,选取同期进行结直肠外科手术的30例非结直肠癌患者的正常结直肠组织作为对照。采用免疫组织化学法检测周期蛋白E和生存素的表达,同时分析周期蛋白E和生存素阳性表达强度与相关临床病理因素的相关性。结果结直肠癌组织组中周期蛋白E和生存素的阳性表达率高于正常结直肠组织[75.0%(45/60)比3.3%(1/30)、50.0%(30/60)比0](χ^(2)=30.077,P<0.001;χ^(2)=16.000,P<0.001);不同性别、组织分化、肿瘤浸润位置周期蛋白E和生存素阳性表达率比较差异均无统计学意义(P>0.05);年龄≥50岁、Dukes分期为Ⅲ~Ⅳ期、发生淋巴结转移者周期蛋白E和生存素阳性表达率均较高(P<0.05);周期蛋白E和生存素阳性表达强度与Dukes分期和淋巴结转移均呈正相关(P<0.01)。结论周期蛋白E和生存素表达与结直肠癌的Dukes分期、淋巴结转移存在密切关系,有助于评估结直肠癌患者临床状态,为疾病治疗提供参考依据。 Objective To explore the clinical significance of cyclin E and survivin in colorectal cancer.Methods Colorectal cancer tissues of 60 patients with colorectal cancer surgically removed in the Third Affiliated Hospital of Anhui Medical University from Jan.2018 to Sep.2021 were collected.The selected specimens were graded and staged,normal colorectal tissues of 30 patients with non-colrectal cancer who underwent colorectal surgery at the same time were selected as controls.The expressions of cyclin E and survivin were detected by immunohistochemistry.The correlation between the positive expression degree of cyclin E and survivin and related clinicopathological factors was analyzed.Results The positive expression rates of cyclin E and survivin in the colorectal cancer tissues were higher than those in the normal colorectal tissues[75.0%(45/60)vs 3.3%(1/30),50.0%(30/60)vs 0](χ^(2)=30.077,P<0.001;χ^(2)=16.000,P<0.001).There was no significant difference in the positive expression rates of cyclin E and survivin between different genders,tissue differentiation degrees and tumor invasion locations(P>0.05).The positive expression rates of cyclin E and survivin were higher in patients with age≥50 years,Dukes stageⅢ-Ⅳ,lymph node metastasis(P<0.05).The positive expression of cyclin E and survivin were positively correlated with Dukes stage and lymph node metastasis(P<0.05).Conclusion The expression of cyclin E and survivin is closely related to the Dukes stage and lymphatic metastasis of colorectal cancer,which is helpful to assess the clinical status of the patients with colorectal cancer and provide reference basis for the treatment.
作者 张劲远 何磊 刘远成 李永海 张承岳 徐烈娟 李瑞 ZHANG Jinyuan;HE Lei;LIU Yuancheng;LI Yonghai;ZHANG Chengyue;XU Liejuan;LI Rui(Department of General Surgery,Hefei First People′s Hospital/the Third Affiliated Hospital of Anhui Medical University,Hefei 230061,China;Department of Anorectal Traditional Chinese Medicine,Hefei First People′s Hospital/the Third Affiliated Hospital of Anhui Medical University,Hefei 230061,China;Department of Gastrointestinal Surgery,Hefei First People′s Hospital/the Third Affiliated Hospital of Anhui Medical University,Hefei 230061,China)
出处 《医学综述》 CAS 2022年第3期610-614,共5页 Medical Recapitulate
基金 合肥市卫健委应用医学研究项目(hwk2019zc001)。
关键词 结直肠癌 周期蛋白E 生存素 Colorectal cancer Cyclin E Survivin
  • 相关文献

参考文献12

二级参考文献74

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2姚卫东,姜惠峰,曲桂梅,于文方,王威,姜蕾,潘旭波,郝俊梅.肝细胞癌组织中endoglin(CD_(105))和VEGF及p57^(kip2)表达与预后的关系[J].肿瘤防治杂志,2005,12(5):360-364. 被引量:11
  • 3熊松柏,杨康.基质金属蛋白酶(MMPs)与肿瘤转移相关性研究进展[J].临床和实验医学杂志,2006,5(11):1850-1851. 被引量:17
  • 4王滔明,许建明,胡乃中.Survivin、COX-2和VEGF在胃癌中的表达及其与预后的意义[J].临床消化病杂志,2007,19(1):35-39. 被引量:8
  • 5Hamilton S R, Vogelstein B, Kudo S, et al. Carcinoma of the colon and reetum[M]. //Hamilton S R, Aaltonen, L A. World health organization classification of turnouts, pathology and ge netics of tumours ofthe digestive system. Lyon: IARC Press, 2000:105-119.
  • 6Minhajat R, Mori D, Yamasaki F, et al. Endoglin(CD105)expression in angiogenesis of colon cancer: analysis using tissue mi croarrays and comparison with other endothelial markers[J]. Virchows Arch, 2006,448(2):127-134.
  • 7Risau W. Angiogenic growth factors[J]. Prog Growth Factor Res, 1990,2(1) :71-79.
  • 8Neufeld G, Tessler S, Gitay-Goren H, et al. Vascular endothe lial growth factor and its receptors[J]. Prog Growth Factor Res, 1994, 5(1):89-97.
  • 9Mesri M, Morales Ruiz M, Ackermann E J, et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting[J]. Am J Pathol,2001,158(5) : 1757-1765.
  • 10Shimizu M, Saitoh Y, Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues[J]. Hum Pathol,1990,21(6):607-612.

共引文献38

同被引文献27

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部